What is the appropriate management of a splenic laceration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Splenic Laceration

Non-operative management (NOM) is the first-line treatment for hemodynamically stable patients with splenic laceration, regardless of injury grade, with success rates exceeding 80-90% and resulting in lower mortality, shorter hospital stays, and preservation of splenic immune function. 1, 2


Initial Assessment and Hemodynamic Determination

Hemodynamic stability must be immediately determined as it dictates the entire management pathway. 3, 2

  • Stable patients are defined as: systolic blood pressure ≥90 mmHg without skin vasoconstriction, altered consciousness, shortness of breath, or vasopressor requirement 1, 2
  • Unstable patients include: systolic BP <90 mmHg with shock signs, OR BP >90 mmHg but requiring bolus infusions/vasopressors, OR base excess >-5 mmol/L, OR shock index >1, OR requiring 4-6 units PRBC within 24 hours 3
  • Transient responders are considered unstable and require operative management 3

Management Algorithm Based on Hemodynamic Status

For Hemodynamically Unstable Patients

Proceed immediately to emergency splenectomy—this is non-negotiable. 3, 2

  • Additional absolute indications for immediate surgery include: peritonitis on examination, bowel evisceration, impalement injury, or other injuries requiring laparotomy 1, 2
  • During surgery, attempt splenic preservation when technically feasible to reduce long-term overwhelming post-splenectomy infection risk 3
  • Laparoscopic splenectomy in acute trauma with active bleeding is not recommended 3

For Hemodynamically Stable Patients

Initiate non-operative management with CT imaging and consider angioembolization. 1, 2

Step 1: Obtain Contrast-Enhanced CT Scan

  • CT with IV contrast is the gold standard with 96-100% sensitivity and specificity for defining injury grade, identifying contrast blush, pseudoaneurysm, and associated injuries 2, 4
  • E-FAST is reserved for unstable patients who cannot undergo CT (91% sensitivity but 42% false-negative rate) 2

Step 2: Grade the Injury

  • Grade III (moderate) is defined as: subcapsular hematoma >50% surface area, intraparenchymal hematoma >5cm, or laceration >3cm depth involving trabecular vessels 1
  • Grading directly influences angioembolization decisions 1

Step 3: Determine Need for Angioembolization

Angioembolization should be strongly considered for all Grade III injuries, even without CT blush. 1, 2

  • Mandatory indications: CT shows contrast blush, pseudoaneurysm, or arteriovenous fistula 1
  • Strong consideration for prophylactic angioembolization in Grade III-V injuries even without blush, as this increases NOM success from 67% to 86-100% 1, 5
  • Use coils rather than temporary agents when performing angioembolization 1
  • Angioembolization should only be performed in centers where it is rapidly available 24/7 1

Critical Monitoring Requirements

NOM should ONLY be attempted if ALL of the following institutional capabilities exist: 1, 2

  • 24/7 capacity to perform emergency hemostatic laparotomy with trained surgeons immediately available 1, 2
  • ICU admission with continuous monitoring for at least the first 24 hours 1, 3
  • Immediate access to angiography/angioembolization 2
  • Immediate blood product availability 2
  • Clinical and laboratory observation with bed rest for 48-72 hours 1, 3

High-Risk Factors Requiring Extra Caution

Three critical factors identified by WSES consensus generate discrepancy and warrant more aggressive intervention: 6, 1

  • Overall injury severity (ISS >25): Higher ISS may warrant prophylactic angioembolization even without blush 1
  • Bleeding diathesis or coagulopathy: Requires intensive monitoring and lower threshold for intervention 6
  • Associated intra-abdominal injuries: May necessitate operative management despite splenic injury being manageable non-operatively 6

Additional high-risk factors include: 2, 7

  • Age >55 years (not an absolute contraindication but warrants prophylactic angioembolization consideration) 1
  • Large hemoperitoneum 2
  • Low admission hematocrit 2
  • Intraparenchymal or subcapsular hematoma (increases failure risk 11-fold) 7
  • Associated traumatic brain injury 2

Transfusion Guidelines

Transfuse for hemoglobin <7 g/dL or signs of ongoing bleeding, inadequate tissue perfusion, or hemodynamic instability. 3, 8

  • The OM group in recent studies required significantly more transfusions (mean 2.6 units vs 0.9 units for NOM) 9
  • Requiring >5 units PRBC is a risk factor for NOM failure but not an absolute contraindication if hemodynamically stable 1

Indications for Conversion to Surgery (NOM Failure)

Convert immediately to splenectomy if ANY of the following occur: 3, 2

  • Persistent hemodynamic instability despite resuscitation 3, 2
  • Significant continued drop in hematocrit requiring continuous transfusions 3, 2
  • Development of peritonitis 3, 2
  • Failed angioembolization with ongoing bleeding 2
  • Abdominal compartment syndrome 1

NOM failure rates: 6, 9

  • 16.1% re-bleeding rate following NOM alone (median 2.3 days) 7
  • 28.6% re-bleeding rate following angioembolization (median 2.0 days) 7
  • Grade III-V injuries have 15.6-fold increased odds of NOM failure 7

Follow-Up Imaging and Monitoring

Repeat CT scan during admission should be considered for: 1

  • Moderate-severe lesions (Grade III-V) 1
  • Decreasing hematocrit 1
  • Vascular anomalies 1
  • Underlying splenic pathology 1
  • Coagulopathy 1
  • Neurological impairment 1

Post-discharge management: 1

  • Routine post-discharge imaging is NOT indicated in uncomplicated cases 1
  • Patients should not be discharged prematurely—delayed rupture risk is highest within first 3 weeks (incidence 0.2-0.3%) 1
  • Normal activity can resume after 6 weeks for moderate-severe injuries 1
  • Grade I-II injuries can be discharged after 24 hours with appropriate advice 7

Special Considerations

Penetrating Trauma

  • Penetrating injuries (sharp objects, gunshot wounds) are strong predictors for operative management 9
  • Splenectomy was performed in 76.9% of surgical cases in recent series 9
  • Penetrating injuries have higher operative splenorrhaphy rates compared to blunt trauma 10

Concomitant Head Injury

  • NOM should still be attempted in patients with traumatic brain injury unless the patient is unstable from intra-abdominal bleeding 1

Thromboprophylaxis

  • Mechanical prophylaxis is safe and should be considered in all patients without absolute contraindication 3
  • LMWH-based prophylactic anticoagulation may be safe in selected patients with blunt splenic injury undergoing NOM and should be started as soon as possible 3

Common Pitfalls to Avoid

  • Do not attempt NOM without full institutional capabilities—this is the most critical error and leads to preventable mortality 1, 2
  • Do not dismiss Grade III injuries as "moderate"—they have significantly higher failure rates and warrant aggressive angioembolization consideration 7
  • Do not rely on age alone as contraindication—age >55 is a risk factor but not absolute contraindication; use prophylactic angioembolization instead 1
  • Do not discharge patients before 24-48 hours—delayed rupture peaks within 3 weeks 1
  • Do not overlook intraparenchymal hematomas on CT—these increase failure risk 11-fold 7

References

Guideline

Management of Grade 3 Splenic Laceration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Splenic Laceration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Splenic Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of blunt splenic injury in a UK major trauma centre and predicting the failure of non-operative management: a retrospective, cross-sectional study.

European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2018

Research

Splenic lacerations: a retrospective analysis of management strategies and clinical outcomes.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2025

Research

Contemporary management of adult splenic injuries: What you need to know.

The journal of trauma and acute care surgery, 2025

Related Questions

What is the management of a splenic laceration seen on computed tomography angiography (CTAP) and can it cause thrombocytopenia?
Does a patient with a grade 3 splenic laceration due to Road Traffic Accident (RTA) require surgical intervention?
What finding warrants surgical intervention in a patient with a splenic injury?
What is the significance of a splenic marginal zone lymphoma (HPLL/ABC - Hairy Cell Leukemia variant, possibly referring to Hairy Cell Leukemia or a similar condition, with ABC possibly referring to a specific variant or classification, such as Aromatic Hydrocarbon Binding Complex, but in this context likely referring to the ABC subtype of Diffuse Large B-Cell Lymphoma or another condition, with HPLL likely being a typo or variation of HCL - Hairy Cell Leukemia, with splenic marginal zone involvement)?
What is the management for a grade 5 splenic (spleen) laceration?
Is a urine culture that reports possible cocci with a colony count of 10,000–49,000 CFU/mL considered a positive result for urinary tract infection?
What are the appropriate diagnostic evaluations and treatment plan for a 15-year-old male with a suspected hamstring injury?
What is the appropriate evaluation and management of clonus in a patient with multiple sclerosis?
How long does gamma‑glutamyl transferase (GGT) remain elevated?
What are the differences between herpes simplex virus type 1 (HSV‑1) and herpes simplex virus type 2 (HSV‑2)?
What is the appropriate treatment for vaginal Candida glabrata infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.